These include tumor size, lymph node stage, expression of estrogen receptor (ER), progesterone receptor (PR), histologic status, overexpression of human epidermal growth factor receptor 2 (HER-2), and Ki-67 proliferation index (Rakha et al., 2014[31]). The gene discussed is PGR; the disease is neoplasm.